BML-210

BML-210 Structure
CAS No.
537034-17-6
Chemical Name:
BML-210
Synonyms
CS-2301;BML-210;CAY10433;BML210, >98%;BML-210, (BML210;BML-210(CAY10433);BML-210 >=98% (HPLC), powder;N-(2-AMINOPHENYL)-N'-PHENYL-OCTANEDIAMIDE;N1-(2-aminophenyl)-N8-phenyl-octanediamide;Octanediamide, N1-(2-aminophenyl)-N8-phenyl-
CBNumber:
CB8254476
Molecular Formula:
C20H25N3O2
Molecular Weight:
339.43
MOL File:
537034-17-6.mol
MSDS File:
SDS
Modify Date:
2023/5/18 11:31:13

BML-210 Properties

storage temp. 2-8°C
solubility DMSO: >20mg/mL
form powder
color white to very faintly yellow
Stability Stable for 2 years from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20° for up to 3 months.

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS07,GHS08,GHS09
Signal word  Danger
Hazard statements  H302-H361-H372-H410
Precautionary statements  P201-P264-P280-P301+P330+P331-P312
WGK Germany  3

BML-210 price More Price(2)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich(India) B8063 BML-210 ≥98% (HPLC), powder 537034-17-6 5MG ₹14451.38 2022-06-14 Buy
Sigma-Aldrich(India) B8063 BML-210 ≥98% (HPLC), powder 537034-17-6 25MG ₹58390.05 2022-06-14 Buy
Product number Packaging Price Buy
B8063 5MG ₹14451.38 Buy
B8063 25MG ₹58390.05 Buy

BML-210 Chemical Properties,Uses,Production

Description

Inhibition of histone deacetylase (HDAC) enzymes by compounds such as trichostatin A can have wide ranging effects in cancer, cell differentiation, and other aspects of gene expression regulation. BML-210 is a small molecule inhibitor of HDAC with an IC50 value of 30 μM when tested in HeLa cell nuclear extracts using 200 μM acetylated fluorometric substrate (substrate available in Cayman’s HDAC Activity and Inhibitor Screening Assay Kits - Item Nos. 10011563 and 10011564).

Definition

ChEBI: A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and 1,2-diaminobenzene.

Biochem/physiol Actions

BML-210 is a synthetic benzamide and is a potential tumor inhibitor. It is used as a therapeutic agent to treat promyelocytic leukemia. In human leukemia cell lines (NB4, HL-60, THP-1, and K562), BML-210 modulates histone deacetylase and promotes apoptosis. BML-210 favors frataxin expression in neurodegenerative disease Friedreich′s ataxia (FRDA). It interacts with myocyte enhancer factor-2 (MEF2) via hydrogen-bonding and prevents histone deacetylase 4 (HDAC4) binding.

BML-210 Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 79)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
ATK CHEMICAL COMPANY LIMITED +undefined-21-51877795 China 32760 60 Inquiry
career henan chemical co +86-0371-86658258 +8613203830695 China 29826 58 Inquiry
Zhejiang J&C Biological Technology Co.,Limited +1-2135480471 +1-2135480471 China 10522 58 Inquiry
InvivoChem +1-708-310-1919 +1-13798911105 United States 6393 58 Inquiry
TargetMol Chemicals Inc. +1-781-999-5354 United States 19973 58 Inquiry
ShenZhen Trendseen Biological Technology Co.,Ltd. 13417589054 China 11681 58 Inquiry
Aladdin Scientific +1-+1(833)-552-7181 United States 57511 58 Inquiry
Amadis Chemical Company Limited 571-89925085 China 131980 58 Inquiry
Beijing Jin Ming Biotechnology Co., Ltd. 010-60605840 18892239720 China 12308 58 Inquiry
Shanghai Zeye Biotechnology Co., Ltd. 021-61998551 13122364865 China 9771 58 Inquiry

BML-210 Spectrum

N-PHENYL-N'-(2-AMINOPHENYL)HEXAMETHYLENEDIAMIDE N-(2-AMINOPHENYL)-N'-PHENYL-OCTANEDIAMIDE BML-210 CAY10433 N1-(2-aminophenyl)-N8-phenyl-octanediamide BML-210(CAY10433) BML-210, (BML210 CS-2301 BML210; BML 210;CAY10433;CAY-10433;CAY 10433 BML210, >98% Octanediamide, N1-(2-aminophenyl)-N8-phenyl- BML-210 >=98% (HPLC), powder Inhibitor,HDAC,BML210,BML-210,BML 210,Apoptosis,inhibit,Histone deacetylases 537034-17-6